Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TYO/4889 stock hub

TYO/4889 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TYO/4889is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
17.3B
Tokyo Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
TYO/4889
In the news

Latest news · TYO/4889

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.7P50 15.8P75 21.7
Trailing P/En/a
P25 11.7P50 15.2P75 22.3
ROE-12.4
P25 -1.6P50 7.1P75 11.9
ROIC-29,400
P25 -0.6P50 6.2P75 14.3
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TYO/4889 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
154
Groups with data
11
Currency
JPY
Showing 154 of 154 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Japan
Country code
JP
Employees
3
Employees Change
-1%
Employees Change Percent
-25
Enterprise value
JPY 14.9B
Exchange
Tokyo Stock Exchange
Financial currency
JPY
First seen
2026-05-10
Industry
Biotechnology
Isin
JP3981100005
Last refreshed
2026-05-10
Market cap
JPY 17.3B
Price
JPY 1,258
Price currency
JPY
Rev Per Employee
35,666,666.67x
Sector
Healthcare
Sic
2834
Symbol
tyo/4889
Website
https://www.renascience.co.jp

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

5
MetricValue
Earnings Yield
-1.49%
EV Earnings
-57.58x
EV/Sales
139.39x
P/B ratio
7.17x
P/S ratio
161.98x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

18
MetricValue
EBIT Margin
-274.77%
Gross margin
95.33%
Gross Profit
JPY 102M
Gross Profit Growth
-23.88%
Gross Profit Growth Q
285.71%
Gross Profit Growth3 Y
31.36%
Net Income
JPY -259M
Net Income Growth Years
2%
Pretax Margin
-240.19%
Profit Margin
-242.06%
Profit Per Employee
JPY -86.3M
Profitable Years
1
ROA
-8.23
Roa5y
-6.87
ROCE
-12.17
ROE
-12.4
Roe5y
-11.97
ROIC
-29,400

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

8
MetricValue
Cagr1y
25.95%
Cagr3y
37.2%
EPS Growth Years
2
Revenue Growth
-23.02x
Revenue Growth Q
200x
Revenue Growth Quarters
1x
Revenue Growth Years
0x
Revenue Growth3 Y
1.28x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

16
MetricValue
Asset Turnover
JPY 0.05
Assets
JPY 2.6B
Cash
JPY 2.4B
Current Assets
JPY 2.6B
Current Liabilities
JPY 144M
Equity
JPY 2.4B
Liabilities
JPY 144M
Long Term Assets
JPY 0
Long Term Liabilities
JPY 0
Net Cash
JPY 2.4B
Net Cash By Market Cap
JPY 13.95
Net Cash Growth
31.14%
Net Debt Equity
JPY -1
Tangible Book Value
JPY 2.4B
Tangible Book Value Per Share
JPY 189
WACC
13.62

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
17.78
Net Working Capital
JPY -1M
Quick ratio
17.01
Working Capital
JPY 2.4B
Working Capital Turnover
JPY 0.05

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-0.1%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
1Y total return
25.93%
200-day SMA
1,919.4
3Y total return
158.32%
50-day SMA
1,654.2
50-day SMA vs 200-day SMA
50under200
All Time High
3,310
All Time High Change
-61.99%
All Time High Date
2025-07-31
All Time Low
263
All Time Low Change
378.33%
All Time Low Date
2024-12-19
ATR
99.09
Beta
1.7
Beta1y
-0.28
Beta2y
0.86
Ch YTD
-11.16
High
1,278
High52
3,310
High52 Date
2025-07-31
High52ch
-61.99%
Low
1,171
Low52
1,012
Low52 Date
2025-05-12
Low52ch
26.82%
Ma50ch
-23.95%
Price vs 200-day SMA
-34.46%
RSI
36.14
RSI Monthly
49.52
RSI Weekly
38.63
Sharpe ratio
0.63x
Sortino ratio
1.12
Total Return
-0.1%
Tr YTD
-11.16
Tr1m
-17.94%
Tr1w
4.75%
Tr3m
-14.36%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
JPY -294M
Operating margin
-274.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
10,532,600%
Shares Insiders
22.65%
Shares Institutions
3.4%
Shares Out
13,776,900
Shares Qo Q
0.4%
Shares Yo Y
0.1%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

37
MetricValue
Average Volume
529,735x
Bv Per Share
189.3
Ch1m
-17.94
Ch1w
4.75
Ch1y
25.93
Ch3m
-14.36
Ch3y
158.3
Ch6m
-34.03
Change
3.54%
Change From Open
4.57
Close
1,215
Days Gap
-0.99
Dollar Volume
657,682,400
Earnings Date
2026-05-07
EBIT
JPY -294M
EPS
JPY -20.35
F Score
1
Fiscal Year End
March
Founded
2,000
Income Tax
JPY 2M
Is Primary Listing
1
Last Earnings Date
2026-02-13
Last Report Date
2025-12-31
Ma150
1,713.2
Ma150ch
-26.57%
Ma20
1,371.9
Ma20ch
-8.3%
Open
1,203
Position In Range
81.31
Price Date
2026-05-08
Ptbv Ratio
7.17
Relative Volume
1.02x
Revenue
107,000,000x
Tax By Revenue
1.87x
Tr6m
-34.03%
Volume
522,800
Z Score
90.91
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does TYO/4889 pay a dividend?

Capital-return profile for this ticker.

Performance

TYO/4889 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+25.9%
S&P 500 1Y: n/a
3Y total return
+158.3%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns TYO/4889?

Insider, institutional, and short-interest positioning.

Institutional ownership
+3.4%
Share of float held by funds and institutions
Insider ownership
+22.7%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.1%
Negative means the company is buying back shares.
Technical

TYO/4889 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
36.1
Neutral momentum band
Price vs 200-day MA
-34.5%
50/200-day relationship not available
Beta (5Y)
1.70
More volatile than the market
Sharpe ratio
0.63
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TYO/4889

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tyo/4889 stock rating?

tyo/4889 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tyo/4889 analysis?

The full report lives at /stocks/tyo/4889/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tyo/4889?

The latest report frames tyo/4889 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tyo/4889 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.